SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 703.10 |
Enterprise Value ($M) | 477.99 |
Book Value ($M) | 250.56 |
Book Value / Share | 2.78 |
Price / Book | 2.81 |
NCAV ($M) | 216.74 |
NCAV / Share | 2.41 |
Price / NCAV | 3.24 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.48 |
Return on Assets (ROA) | -0.47 |
Return on Equity (ROE) | -0.58 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 14.72 |
Current Ratio | 14.72 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 263.86 |
Assets | 297.67 |
Liabilities | 47.12 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -143.72 |
Net Income | -134.24 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -121.14 |
Cash from Investing | 70.70 |
Cash from Financing | 135.52 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Eventide Asset Management, Llc | 0.00 | -100.00 | |
13G/A | Venrock Healthcare Capital Partners II, L.P. | 1.20 | -80.35 | |
13G/A | Fairmount Funds Management LLC | 0.40 | -91.23 | |
13G/A | Redmile Group, LLC | 9.90 | 65.06 | |
13G/A | Citadel Advisors Llc | 1.40 | ||
13G/A | Biotechnology Value Fund L P | 8.90 | 85.15 | |
13G/A | Bain Capital Life Sciences Fund, L.P. | 9.99 | 174.15 | |
13G/A | Logos Global Management LP | 8.30 | 124.01 | |
13G | Point72 Asset Management, L.P. | 6.20 | ||
13G/A | Adage Capital Partners Gp, L.l.c. | 7.15 | 34.56 | |
13G | Fmr Llc | 12.37 | 622.78 | |
13G/A | Federated Hermes, Inc. | 4.41 | -23.39 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
410,054 | 2,915,126 | 14.07 | |
714,693 | 5,318,897 | 13.44 | |
241,435 | 1,652,467 | 14.61 | |
210,823 | 1,698,390 | 12.41 | |
(click for more detail) |
Similar Companies | |
---|---|
AMPH – Amphastar Pharmaceuticals, Inc. | AMRX – Amneal Pharmaceuticals, Inc. |
ANAB – AnaptysBio, Inc. | APLS – Apellis Pharmaceuticals, Inc. |
ARQT – Arcutis Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io